150 related articles for article (PubMed ID: 11852162)
1. The quality of conduct in Japanese clinical trials: deficiencies found in GCP inspections.
Ono S; Kodama Y; Nagao T; Toyoshima S
Control Clin Trials; 2002 Feb; 23(1):29-41. PubMed ID: 11852162
[TBL] [Abstract][Full Text] [Related]
2. Quality of Japanese clinical trials estimated from good clinical practice audit findings.
Saito K; Kodama Y; Ono S; Mutoh M; Kawashima S; Fujimura A
Am J Ther; 2006; 13(2):127-33. PubMed ID: 16645429
[TBL] [Abstract][Full Text] [Related]
3. Reliability of Japanese clinical trials estimated from GCP audit findings.
Saito K; Kodama Y; Ono S; Maida C; Fujimura A; Miyamoto E
Int J Clin Pharmacol Ther; 2008 Aug; 46(8):415-20. PubMed ID: 18793583
[TBL] [Abstract][Full Text] [Related]
4. Recent changes in quality in Japanese clinical trials.
Saito K; Kodama Y; Ono S; Fujimura A
Ann Pharmacother; 2004 Jan; 38(1):151-5. PubMed ID: 14742810
[TBL] [Abstract][Full Text] [Related]
5. Current status of quality in Japanese clinical trials.
Saito K; Kodama Y; Ono S; Mutoh M; Kawashima S; Fujimura A
Contemp Clin Trials; 2005 Aug; 26(4):503-9. PubMed ID: 16054582
[TBL] [Abstract][Full Text] [Related]
6. Compliance with Good Clinical Practice in oncology registration trials in Japan.
Yonemori K; Hirakawa A; Ando M; Hirata T; Shimizu C; Katsumata N; Tamura K; Fujiwara Y
Ann Oncol; 2011 Jun; 22(6):1451-1456. PubMed ID: 21119030
[TBL] [Abstract][Full Text] [Related]
7. [Implementation of new Japanese GCP and the quality of clinical trials--from the standpoint of the pharmaceutical industry].
Ebi O
Gan To Kagaku Ryoho; 1997 Oct; 24(13):1883-91. PubMed ID: 9350232
[TBL] [Abstract][Full Text] [Related]
8. Clinical trials and the new good clinical practice guideline in Japan. An economic perspective.
Ono S; Kodama Y
Pharmacoeconomics; 2000 Aug; 18(2):125-41. PubMed ID: 11067647
[TBL] [Abstract][Full Text] [Related]
9. [In order to perform clinical trials efficiently in Japan--important issues in medical institutions raised by the GCP on-site review].
Akiyama T; Furuta M; Yamada H
Nihon Kokyuki Gakkai Zasshi; 2006 Aug; 44(8):541-9. PubMed ID: 16972610
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of clinical trials by Ethics Committees in Germany--results and a comparison of two surveys performed among members of the German Association of Research-Based Pharmaceutical Companies (vfa).
Russ H; Busta S; Jost B; Bethke TD
Ger Med Sci; 2015; 13():Doc02. PubMed ID: 25698912
[TBL] [Abstract][Full Text] [Related]
11. Promoting good clinical practices in the conduct of clinical trials: experiences in the Department of Veterans Affairs Cooperative Studies Program.
Sather MR; Raisch DW; Haakenson CM; Buckelew JM; Feussner JR;
Control Clin Trials; 2003 Oct; 24(5):570-84. PubMed ID: 14500054
[TBL] [Abstract][Full Text] [Related]
12. 'Screening audit' as a quality assurance tool in good clinical practice compliant research environments.
Park S; Nam CM; Park S; Noh YH; Ahn CR; Yu WS; Kim BK; Kim SM; Kim JS; Rha SY
BMC Med Ethics; 2018 Apr; 19(1):30. PubMed ID: 29699559
[TBL] [Abstract][Full Text] [Related]
13. [New Japanese GCP--from the standpoint of a sponsor].
Ebi O
Gan To Kagaku Ryoho; 1998 Apr; 25(5):650-62. PubMed ID: 9571962
[TBL] [Abstract][Full Text] [Related]
14. [Development of anti-cancer drugs under new renewed GCP--from the viewpoint of drug development company developer].
Ueno T; Kobayashi T; Inoue K; Yanagi Y; Yamada Y
Gan To Kagaku Ryoho; 1998 Apr; 25(5):663-70. PubMed ID: 9571963
[TBL] [Abstract][Full Text] [Related]
15. [The GCP directive--consequences for clinical drug research].
Gluud CN
Ugeskr Laeger; 2003 Apr; 165(16):1662-4. PubMed ID: 12756824
[TBL] [Abstract][Full Text] [Related]
16. Experiences with GCP in the pharmaceutical industry [corrected].
Rämsch KD
Methods Find Exp Clin Pharmacol; 1993 May; 15(4):237-40. PubMed ID: 8240533
[TBL] [Abstract][Full Text] [Related]
17. Auditing of clinical research ethics in a children's and women's academic hospital.
Bortolussi R; Nicholson D
Clin Invest Med; 2002 Jun; 25(3):83-8. PubMed ID: 12137256
[TBL] [Abstract][Full Text] [Related]
18. American Society of Clinical Oncology policy statement: oversight of clinical research.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2377-86. PubMed ID: 12721281
[TBL] [Abstract][Full Text] [Related]
19. WHO guidelines for good clinical practice (GCP) for trials on pharmaceutical products: responsibilities of the investigator.
Idänpään-Heikkilä JE
Ann Med; 1994 Apr; 26(2):89-94. PubMed ID: 8024733
[TBL] [Abstract][Full Text] [Related]
20. [ICH-GCP Guideline: quality assurance of clinical trials. Status and perspectives].
Englev E; Petersen KP
Ugeskr Laeger; 2003 Apr; 165(16):1659-62. PubMed ID: 12756823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
